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months, At 3 yrs, we report 2 rostonosos, 1 treated by PTA alone, 1 by PTA 
and stent. All arteries remained patent, 
Conclusion: PTA el infrarenat aorta. ,)cctt.lSlVO dlse~, ;os is sate and cOco- 
live Slant placement are necessary In most el the cases, Leng term results 
ar~t o~collent This technique is an alternative to surgery 
"o"' So.ported C..o,,d Ang, op,.,y (..CA) In 
. . . . . . . . . . . . . .  Patients With Symptomatic Coronary Artery 
Disease: Acute and Long Term Results 
F/A, Shawl, A, Efstrotieu, F, Lapetlna, A, Dukevoic, T, Shahab, 8,B, Heft, 
K,G, DO~lghnrty, Wa,~hingtorl Adventist H&~piIal. dikes# Prqrk. MD. USA 
C~rolid endarteroctomy (CE) in tl~fl pro~onco el r~ymptomatte coronary artery 
disease (SCAD) has boon associated with high molbidily and mortality Of 
06 pie with SCAD who undnrwenl SSCA, 77 were conaiderod poor CE 
candidates (g had scent MI, 27 had 8ovate LV dy~lunclien with Class III or 
IV nngina pre~ent in 50), Twenty leHt wore ,g0 years, 0 l~nd eontralatorol 
carotid o~oluslen, 20 had bilateral atano~is. 70%, 52 presented with TIA's or 
eVA, 5 scent h~miplegla, and evolving stroke was prose~t In t, ~CA was 
undaftakon in g0 internal and 7 common carotid artenea with implanlatlca el 
14t Palma~, stent~ with everlappieg sleet in 33% to Incroaae radial stronglh. 
Pmeed~lr~l succo,~ we~ff 100% (tl~(:;l~ldlnt155 w!th combiner4 or at~god PTCA) 
rodllclng the carotid Me.healS from 86 t 7% to 5 ~ 2% There were no deaths, 
MI or meier strokes, hut, 3 pts l~r~d miner neurolofllc deficit which resolved 
in 7 day& Moat (75%1 were discharged within 24 hetlrs, On fellow.up (g t 
5 months), 6 p16 died teen combrava~c~dl~r) and 2 with known LV tl~mmbus 
so(feed minor ~trekn In 71 p(s eligible for 6 monll~ anglograplric (4~ pts) 
of uttr~se~,md (Tt pts) follow.up ~eveidcd, t asymptomatic ioslenotHs, wl~lch 
wa~ ro.diltUed 
Conchrsien: SSCA is associated with n high success tats, low recurrence 
rat~ and infrequent complications, 
L~8:~ Is Combined Parcutaneous Carotid Artery 
- Slanting and Coronary or Extra-Coronary Artery 
Angloplasty a Safe Procedure? 
JC. Laborde, J, Faiadet, B Cassagnoau, C Jordan, R Calms, T Joseph, 
J P Laumnt, J Memo Unitd de Cmdlotoqie Infen.ent~onnelle, Chn~que 
P&~ltr, TouletL~o, F~anct~ 
Background: To evaluate the risks and bnnohts el carotid orient stontmg m 
comhtnation with coroner's, or oxtra-c"~renary angioplasty dunng the same 
setting in patients at risk for ondartorectomy. 
Mefhc~d.~ From 4/15/96 to 7,'20197, we pertormod combmed procedures 
tn 22 pahonts ( t 8 males, mona ago 71 2 t 4 ? years, range: 62-78), consid- 
ered at nsk fo~ su~tcal ondarlorectomy Assoclahon of caretid stontmg and 
coronary ang~oplasty (balloon +stont: 5 pts, balloon angloplasty atone: 4 pls, 
3therectomy + balloon 2mq~oplasty 1 pt) was performed in 10 pts, bilateral 
camt~d stontmg ,~ 9 pts; carehd slenlmg ar(d ponphoral angloplasty (renal 
stentmg: 1 pt; ihae stenhng: 1 pt; femoral angloplasty: 1 Dr) in 3 pie. Twelve 
pts (55%'t had neurologlc symptoms incladtng transient ischomic attacks (8 
pts) and recent stroke (4 pts). The remaining pts wore asymptomatic. Twenty 
pts (91%4 had severe coronary associatod orion,/lesions. Moan diameter 
stonosls of the carehd Ios~ons was ?9"0 frange: 65-95%). All pabonts wore 
treated without downtlow carotid protection. 
Results: Procedural success was achieved ~n 21/22 Dis (955%) Imme- 
diate comphcahons conmsfed ot 1 rumor stroke (45%,) At 30 days follow-up, 
we obsewod one death t4,5",,) duo to cardiac arrest, non fatal cardiac events 
m 2 pts (1 heart lailure, 1 ventncular tachycardia), 1 abdominal haemorrago, 
no MI, no stroke. At follow-up, mean 5,7 t 4.1 months, we observed { 2 
cardiac deaths, 2 PTCA for restonoms, no MI, no stroke 
Conclusfons: Combination of carotid artery stentlng with controlatoral 
carotid stoat implantahon or w~th coronary and extra-coronary angtoplasty 
dunng the same setting appeared not to mcrease significantly the ask el 
carotid stenting in high-risk pts lor surgery, 
~ L a c k  of Benefit of Stentlng Compared to Bal loon 
Angloplasty for Native Coronary Stenoses in 
Diabet ics  
M.H. Ghatoun, GC. Timmls. T, Catlin, D, Aliabadi. R+D. Safian, 
J.A. Goldstem, W.W O'Neill Wdliam Beaumont Hospital. Royal Oak, 
Mich.gan. UqA 
As suggested m recent teals of balloon angioplasty vs bypass surgew, di- 
abetic patients may tare less well with angioplasty, Intracorenary stenting 
reduces restenosis rates in pts undergoing elective angioplasty of native 
coronary stenoses. However, whether stenting conlers such benefits in dia- 
betics has not been established. Therefore, we retrospectively analyzed the 
outcome over 9 months in diabetic patients undergoing balloon angioplasty 
alone (N = 154) or elective stonting (N ~ 87) of native coronary lesions, End- 
points el the study included target vessel rovascularizatlon (TVR) and major 
clinical outcomes (MI, stroke and death), No differences wee found between 
groups with aspect to ago or gender. Acute success rotes between balloon 
nnd stont groups were similar. Over 9 months, them wee no ai~niflennt 
difference between angioplasty end stent groups with regard to TVR roto~ 
(24% vs 28"/0, P = NS), MI (4,3% vs 3,8% P ~ NS), stake (P,~, vs 9.6%, P 
== NS) or death (? R"/,, v~ .q,2%, P = NS), These data suggest that oomparod 
with balloon nngioplaaty, elective intmooronaly stenting dens not provide 
additional benefit in diabolic pts undergoing percutanoega rovascgl~nZ~tlon 
el nntive ceronnry lesions, The moat elteCtlVe revaact!!rletolion strategy for 
tl~nso pts has not boon dotetmmed 
' ==== ~---' (111]I]~B4 j The Effect of Dlel~tee and Revas©u!er!zetlon 
+ - - ~  Technique on Eerly Outcomes 
GC Timmia, R T Collie, L Tomaka, W.W, O'Ned! Wtlham B~+umont 
Hospffal, Revel/Oak, MI, US.4 
Beeal.lse el the interaction at diabetes (DM) and mvasculalizattee technique 
on eulcomea we interrogated our !nt~n/onhenal Outcomes Regtst~ Database 
tel the following In,hospital events: death, IofalClion (b(3lh qMI and nqMl) 
SllOkO, lllgellt 6lllglca! levascu!arl~aften, ca~iel~nl~ shock~ and reoo~Iuslon 
a~ inlhteeced by DM status (beth type I and II) m~d by procedure (PTCA 
vs sleet) There were 17',00g patients (pts) having procedures tree t,1,94 
Ihreugh 3,31-97, 4,056 (29%) were diabetic (type Iaad It) but stmdar m age 
gender and disease seventy There wore 62 and 104 doatbs m the OM v,s 
non.DM pls (1 25%, vS 0.86%; p = 0.01 cJ). This was duo to an eKcess mo~akty 
m PTCA pts with DM (1,22% vs 0.83% non, DM PTCA pts; p = 002.5) There 
was no slgndleant mortalLty dlllemn¢o in sleeted DM vs non-DM pts tt 48% 
vs 1 05%; p =, 0.3g) Roocclusions wore mere likely to complicate PTCA 
regardless el the presence o! DM (1.68%, vs 0.49% with stoats; p = 0032) of 
Its ab~enc~ (t 7~i% vs O~ 75% wtth stoats; p = O.OOt/ Converser K MIs ¢~'re 
more lreqnont with stents (2.33% vs 1.29%; p = 0.000) but wore equally 
dlstnbuled beh~oon DM and non-DM pts regardless el procedure ~,~reover, 
combining ~lt endpomts there was no stgmllcant difference per d~abot~c status 
(p = 0.38) regaElloss ot procedure (stool: p = 027; PTCA: p = 0.48). No other 
ondpetnt wos intktonced by DM status Iocludmg acute or delayed reoccluston 
Conclusion: Hospital mortality is higher in OM pts alter PTCA but not alter 
stealing. However, the combined endpoint was not influenced by diabetic 
status bul rather by procedure mcluding polar differences in reoo=lusmn and 
MI, These early outcemes unno~score the importance el adiunchve therapy 
~1_8-8~ Predictors of Target Lesion Revascularization in 
- -  Diabetic Patients Treated With Palmaz-Schatz 
Stents 
A AbzzaLd, G.S Mmtz, B Otlaca. KM Kent, L F Sailer. A O Plchard. 
H Wu, R Mehran, T Bucher, J J Popes, M B Leon Washmgton Hospital 
Center, Washmgton, DC USA 
To ovahtate the predicterS el target leslol~ ~eva~culartzatlon (TLR) m diabetics 
treated w~th Palma=-Schatz stoats, t 51 native vessel lesions m 130 consec- 
utwe pts were analysed using ( lt  pre and post-intervention mtravascular 
ultrasound (IVUS: reterence and lesion ar(eeal, lumen, and plaque areas 
and plaque burden (plaque/adenal area)} and t2) quanhtative angtography 
{QCA: relorence diameter, mmimum htmen diameter (MLD), and diameter 
stonosis (%DS)}. All pts were followed for at least 1 yr. Univanate predictors 
included 
TLR no TLR p 
N 39 112 
h ,:,oh~'l Iher3py 61 ~o 44% O 001 
QCA 
R~lelelIce 2 95 t 0 F,8 3 10 t 0 66 e 05 
Pest MLDt%) 268 '~ 049 294 : 066 003 
IVUS 
Rt!tetel~t~ lumer~ area tan12) 7 50 .* 1 79 9 57 t 3 48 000t 
Referenceplaque bulden 52 t 12 47 : 12 0066 
Postleslon lumen area tam ?) 6 70 .* 1 74 7 53 t 2 57 0 02 
Post MLD (am) 2.55 t O 28 2 76 t 0 52 0 002 
Insulin-treated diabet,cs had a TLR rate of 3t°o (vs 19% for non-insulin 
diabetics). Using multivariate logistic regression analysis, the mdependent 
predictors of TLR were insulin therapy (Odds ratio = 0167. p = 0.048) and 
IVUS final lumen area (Odds ratio = 0.034. p = 0.011). 
We Conclude: Diabetic pts, especially those treated with insulin, have a 
high rate of TLR 1 yr after stent placement (25% overall, 31% for insulin- 
treated diabetics). However. even in these pts the IVUS final lumen CSA is 
an important predictor of late events. 
